The Scientific Research Team at iTeos Therapeutics conducts cutting-edge research to advance the development of innovative immunotherapy treatments for cancer patients. Comprised of experienced scientists and advisors, the team focuses on pre-clinical studies, biomarker identification, and translational medicine to optimize therapeutic strategies and enhance patient outcomes. Through collaboration and rigorous scientific inquiry, the team strives to identify novel cancer targets and validate new treatment approaches.
View all